PFO Closure Trials

Thanks! Share it with your friends!

Close

PFO Closure Trials Press

The PFO Closure Trials  Randomized Evaluation of Recurrent Stroke Comparing PFO Closure to Established Current Standard of Care Treatment (RESPECT) and PC Trial , presented at TCT 2012 after many years of anticipation, were finally published in the New England Journal of Medicine.

Both of these studies were randomized, controlled clinical trials, and both missed their primary end point, a finding that disappointed many hoping that closure of patent foramen ovale (PFO) with the Amplatzer occluder (St Jude Medical, St Paul, MN) would prevent stroke recurrence in patients who previously had a cryptogenic stroke.

Here’s some press and a few differing  PFO closure trial perspectives:

(you may need account access to Heartwise /Medscape to read full articles (free) )

LinkedInFacebookWordPressEvernoteShare

Comments

[…] what may have contributed to it (doctors found a small PFO) are certainly making waves again about PFO closure.  Will he be able to play professional hockey again?  It is certainly too early to tell.  Some […]

[…] defect (PFO) is not what most stroke survivors are offered after they find they have a PFO.  The PFO closure procedure is now controversial and oftentimes not approved by […]

[…] the Transcatheter Cardiovascular Therapeutics (TCT) 2012 conference, the RESPECT trial was presented.  This trial was supported by St. Jude and the trial was performed at 69 sites in […]

Write a comment